A Boy With Blau Syndrome Misdiagnosed as Refractory Kawasaki Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Blau syndrome is a systemic autoinflammatory disease presenting with non-caseating granulomatous dermatitis, chronic uveitis, and arthritis. It is caused by a gain-of-function variant of the nucleotide-binding oligomerization domain protein 2 gene, which leads to the overactivation of inflammatory cytokines and eventually causes autoinflammation. Since the symptoms of Blau syndrome are nonspecific and usually do not appear simultaneously, it is challenging to differentiate Blau syndrome from other inflammatory disorders. This is a case report of a 13-month-old boy who had suffered from recurrent skin rash and fever. The patient was previously misdiagnosed as refractory Kawasaki disease twice and was treated with intravenous immunoglobulin and systemic glucocorticoid, which only resulted in transient improvement of the symptoms. He was eventually diagnosed with Blau syndrome.
Abstract
Blau syndrome is a systemic autoinflammatory disease presenting with non-caseating granulomatous dermatitis, chronic uveitis, and arthritis. It is caused by a gain-of-function variant of the nucleotide-binding oligomerization domain protein 2 gene, which leads to the overactivation of inflammatory cytokines and eventually causes autoinflammation. Since the symptoms of Blau syndrome are nonspecific and usually do not appear simultaneously, it is challenging to differentiate Blau syndrome from other inflammatory disorders. This is a case report of a 13-month-old boy who had suffered from recurrent skin rash and fever. The patient was previously misdiagnosed as refractory Kawasaki disease twice and was treated with intravenous immunoglobulin and systemic glucocorticoid, which only resulted in transient improvement of the symptoms. He was eventually diagnosed with Blau syndrome.
참고문헌 (17)
- Kurokawa T, "Ocular manifestations in Blau syndrome associated with a CARD15", Nod2 mutation, 2003, pp.110, 2040~2044
- Son S, "Altered cytokine profiles of mononuclear cells after stimulation in a patient with Blau syndrome", Rheumatol Int, 30, pp.1121~1124 (2010)
- Woojoong Kim, "A familial case of Blau syndrome caused by a novel NOD2 genetic mutation", Clinical and Experimental Pediatrics, 59, pp.5~9 (2016), 대한소아청소년과학회
- Leong KF, "Blau syndrome associated with nucleotide-binding oligomerization domain containing 2 mutation in a baby from Malaysia", Indian J Dermatol, 64, pp.400~403 (2019)
- PaÇ Kisaarslan A, "Blau syndrome and early-onset sarcoidosis : a six case series and review of the literature", Arch Rheumatol, 35, pp.117~127 (2019)
- Iriqat S, "Blau syndrome : a case report from Palestine", Pediatr Rheumatol Online J, 19, pp.138~ (2021)
- Jindal AK, "A young female with early onset arthritis, uveitis, hepatic, and renal granulomas : a clinical tryst with Blau syndrome over 20 years and case-based review", Rheumatol Int, 41, pp.173~181 (2021)
- Okazaki F, "A novel mutation in early-onset sarcoidosis", Blau syndrome : an association with Propionibacterium acnes, 2021, pp.19, 18~
- Su J, "Blau syndrome with pulmonary nodule in a child", Australas J Dermatol, 62, pp.217~220 (2021)
- Wang W, "Thalidomide may be an effective drug for Blau syndrome : a case report", Ann Palliat Med, 11, pp.2538~2543 (2022)
- Matsuda T, "Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation", Ann Rheum Dis, 79, pp.1492~1499 (2020)
- Rosé CD, "Pediatric granulomatous arthritis : an international registry", Arthritis Rheum, 54, pp.3337~3344 (2006)
- Mourad F, "Sinus of valsalva aneurysm in Blau’s syndrome", J Cardiothorac Surg, 5, pp.16~ (2010)
- Gupta A, "Kawasaki disease for dermatologists", Indian Dermatol Online J, 7, pp.461~470 (2016)
- Kim GB, "Epidemiology of Kawasaki disease in South Korea : a nationwide survey 2015-2017", Pediatr Infect Dis J, 39, pp.1012~1016 (2020)
- Aróstegui JI, "NOD2 gene-associated pediatric granulomatous arthritis : clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort", Arthritis Rheum, 56, pp.3805~3813 (2007)
- Lu L, "Blau syndrome with good reponses to tocilizumab : a case report and focused literature review", Semin Arthritis Rheum, 47, pp.727~731 (2018)